<p><h1>Continuous Glucose Monitoring System for Elderly Market: Challenges, Opportunities, and Growth Drivers and Major Market Players forecasted for period from 2024 - 2031</h1></p><p><strong>Continuous Glucose Monitoring System for Elderly Market Analysis and Latest Trends</strong></p>
<p><p>A Continuous Glucose Monitoring (CGM) system is a device that measures glucose levels in the body throughout the day and night. It consists of a small sensor that is inserted under the skin to monitor glucose levels in the interstitial fluid and a transmitter that sends the data to a receiver or smartphone.</p><p>The Continuous Glucose Monitoring System for Elderly Market is witnessing significant growth due to the rising prevalence of diabetes among the elderly population. According to the International Diabetes Federation, the population of people aged 65 and above with diabetes is expected to increase by 120% between 2019 and 2045. The CGM system provides real-time data, alerts, and warnings, enabling timely intervention and management of blood glucose levels. It eliminates the need for frequent fingerstick tests, providing convenience and enhancing the quality of life for elderly individuals.</p><p>Another factor driving the market growth is the technological advancements in CGM systems. The development of accurate and reliable sensors, improved connectivity, and integration with other devices such as insulin pumps have further enhanced the functionality of CGM systems. Integration with smartphones, smartwatches, and other wearable devices has made monitoring glucose levels more accessible and convenient for elderly individuals.</p><p>The continuous glucose monitoring system for elderly market is also witnessing a trend towards miniaturization of devices. Manufacturers are focusing on developing smaller and more discreet sensors and transmitters, making it less intrusive for elderly individuals to wear the devices continuously.</p><p>In conclusion, the Continuous Glucose Monitoring System for Elderly Market is expected to witness significant growth at a CAGR of 5.60% during the forecast period. The increasing prevalence of diabetes among the elderly population and technological advancements in CGM systems are driving the market growth. Additionally, the trend towards miniaturization of devices is making CGM systems more convenient and user-friendly for elderly individuals.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reportprime.com/enquiry/request-sample/8731">https://www.reportprime.com/enquiry/request-sample/8731</a></p>
<p>&nbsp;</p>
<p><strong>Continuous Glucose Monitoring System for Elderly Major Market Players</strong></p>
<p><p>The continuous glucose monitoring system (CGMS) market for the elderly is highly competitive, with major players vying for market share. Some prominent companies in the market include Abbott Diabetes Care Inc., Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment, and San Meditech.</p><p>Abbott Diabetes Care Inc. offers the FreeStyle Libre system, a CGM that provides real-time glucose readings and trends without the need for routine fingerpricks. The company has experienced significant growth in recent years due to the increasing adoption of its innovative technology. Abbott Diabetes Care has expanded its market reach globally and has successfully gained a significant market share in the CGMS market. </p><p>Dexcom is another key player in the CGMS market, known for its Dexcom G6 system. The company has been witnessing substantial market growth due to ongoing product enhancements improving accuracy and reliability. Dexcom has a strong presence in both the domestic and international CGMS markets.</p><p>Medtronic, a well-established player in the medical device industry, offers the Guardian Connect system for continuous glucose monitoring. The company has a wide product portfolio and a global presence, which has contributed to its growth in the CGMS market. Medtronic has been actively investing in research and development to improve its CGM technology and expand its market share.</p><p>Senseonics Holdings is known for its Eversense CGM system, which offers long-term implantable sensors for continuous glucose monitoring. The company has witnessed steady growth in the market due to its unique offering and growing customer base. Senseonics Holdings has been striving to expand its market share further through partnerships and collaborations.</p><p>While information about specific sales revenue is not available, these companies are experiencing significant growth in the CGMS market. The market for CGM systems for the elderly is expected to grow further in the coming years due to factors such as the rising diabetic population, increasing awareness about diabetes management, and technological advancements in CGM systems.</p><p>The global CGM market size was valued at USD 3.6 billion in 2020 and is projected to reach USD 9.1 billion by 2028, growing at a CAGR of 12.6% during the forecast period. The market's growth is driven by factors such as the increasing prevalence of diabetes, growing adoption of CGM systems, and favorable reimbursement policies.</p><p>Overall, the CGMS market for the elderly is highly competitive, with companies like Abbott Diabetes Care Inc., Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment, and San Meditech leading the way. These companies have shown significant market growth and are expected to continue expanding their market share in the future.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Continuous Glucose Monitoring System for Elderly Manufacturers?</strong></p>
<p><p>The Continuous Glucose Monitoring (CGM) System for Elderly market is experiencing significant growth and is expected to continue this trend in the future. CGM systems are used to monitor glucose levels in elderly individuals, helping to manage diabetes and prevent complications. The market is driven by the increasing prevalence of diabetes among the elderly population. CGM systems offer benefits such as real-time glucose monitoring, early detection of hypo and hyperglycemia, and improved diabetes management. Technological advancements, such as the development of wearable devices and smartphone integration, are expected to further fuel market growth. Overall, the CGM system market for the elderly shows promising growth prospects and a bright future outlook.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reportprime.com/enquiry/pre-order/8731">https://www.reportprime.com/enquiry/pre-order/8731</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Continuous Glucose Monitoring System for Elderly Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Wearable</li><li>Implantable</li></ul></p>
<p><p>The Continuous Glucose Monitoring System for Elderly market includes two types: wearable and implantable devices. Wearable devices are external devices that can be comfortably worn on the body, such as on the wrist or arm. These devices continuously monitor the levels of glucose in the elderly person's bloodstream. On the other hand, implantable devices are inserted under the skin and provide real-time glucose readings without the need for external devices. Both types of devices aim to improve the management and monitoring of glucose levels in elderly individuals, allowing for better control of diabetes and related conditions.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reportprime.com/checkout?id=8731&price=3590">https://www.reportprime.com/checkout?id=8731&price=3590</a></p>
<p>&nbsp;</p>
<p><strong>The Continuous Glucose Monitoring System for Elderly Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals & Clinics</li><li>Homecare Settings</li></ul></p>
<p><p>The market application of Continuous Glucose Monitoring Systems for elderly includes their usage in Hospitals & Clinics and Homecare settings. In hospitals and clinics, these systems are utilized to monitor the blood sugar levels of elderly patients continuously, allowing healthcare professionals to make timely interventions or adjustments in treatment plans. On the other hand, in homecare settings, these systems are beneficial for elderly individuals who prefer to manage their blood glucose levels independently, enabling them to track their readings and maintain a healthier lifestyle.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Continuous Glucose Monitoring System for Elderly Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The continuous glucose monitoring system (CGMS) market for the elderly is expected to witness significant growth in various regions, including North America (NA), Asia-Pacific (APAC), Europe, the United States (USA), and China. North America is anticipated to dominate the market due to the presence of a well-established healthcare infrastructure and increasing elderly population. It is forecasted to hold a market share of approximately 35%. APAC is expected to exhibit rapid growth, driven by a rising geriatric population and increasing awareness of diabetes management, with a projected market share of around 28%. Europe is also expected to have a substantial market share of approximately 27%. The United States and China are forecasted to contribute market shares of approximately 5% and 4%, respectively.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reportprime.com/checkout?id=8731&price=3590">https://www.reportprime.com/checkout?id=8731&price=3590</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reportprime.com/enquiry/request-sample/8731">https://www.reportprime.com/enquiry/request-sample/8731</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reportprime.com/</p>